Kevin is an associate in Cooley’s fund formation practice group. He focuses his practice on the formation and representation of private investment funds, including venture capital and private equity funds.
Vanara Capital Announces Firm Launch and Strategic Partnership With TPG
August 19, 2025
Cooley advised Vanara Capital, an investment management firm focused on providing flexible capital solutions for growth-stage technology companies, on its strategic partnership with TPG NEXT.
Sentinel Global Closes $213.5 Million Inaugural Fund
June 24, 2025
Cooley advised Sentinel Global, a venture capital firm dedicated to connecting visionary founders with real-world adopters, on the close of its inaugural fund, Sentinel Fund I, with committed capital totaling $213.5 million.
Amplify Partners Announces Three New Funds Totaling $900 Million
June 18, 2025
Cooley advised Amplify Partners, an early-stage venture capital firm dedicated to technical founders, on the formation of three new funds – Fund 6, Fund 6 Select and Amplify Bio – with a combined $900 million in capital.
Andreessen Horowitz Launches $500 Million First-of-Its-Kind Biotech Ecosystem Venture Fund
January 10, 2025
Cooley represented Andreessen Horowitz (a16z), a Silicon Valley-based venture capital firm that backs bold entrepreneurs building the future through technology, on the $500 million closing of its Biotech Ecosystem Venture Fund – a newly formed, first-of-its-kind venture capital fund to fuel broader innovation in human health.
